Automate Your Wheel Strategy on HUM
With Tiblio's Option Bot, you can configure your own wheel strategy including HUM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HUM
- Rev/Share 1021.3292
- Book/Share 151.7766
- PB 1.9171
- Debt/Equity 0.6902
- CurrentRatio 1.9522
- ROIC 0.0488
- MktCap 34878880000.0
- FreeCF/Share 20.2341
- PFCF 14.3005
- PE 22.1804
- Debt/Assets 0.2499
- DivYield 0.0122
- ROE 0.0902
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | HUM | Raymond James | Market Perform | Outperform | -- | $315 | May 1, 2025 |
| Initiation | HUM | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | Oct. 11, 2024 |
| Upgrade | HUM | Bernstein | Market Perform | Outperform | -- | $308 | Oct. 8, 2024 |
| Downgrade | HUM | TD Cowen | Buy | Hold | $402 | $261 | Oct. 7, 2024 |
| Downgrade | HUM | Jefferies | Buy | Hold | $519 | $253 | Oct. 7, 2024 |
| Downgrade | HUM | Piper Sandler | Overweight | Neutral | $392 | $274 | Oct. 3, 2024 |
| Downgrade | HUM | Leerink Partners | Outperform | Market Perform | $400 | $250 | Oct. 2, 2024 |
| Downgrade | HUM | Stephens | Overweight | Equal Weight | $400 | $250 | Oct. 2, 2024 |
| Downgrade | HUM | BofA Securities | Neutral | Underperform | $376 | $247 | Oct. 2, 2024 |
News
New Research from Humana Finds Value-Based Care Delivers Higher Quality of Care for Heart Failure Patients
Published: August 21, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Value-based care delivers a higher quality of care and better medication prescription adherence to evidence-based medicine for Medicare Advantage patients diagnosed with heart failure, according to findings released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its latest Value-Based Care Issue Brief. Heart failure continues to affect a growing number of Americans, with 11.4 million expected to be diagnosed by 2050. Patients with hea.
Read More
CNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana's strong Medicare Advantage growth and higher ROE give it an edge over Centene, which faces earnings pressure and OBBB Act headwinds.
Read More
Here's Why Humana (HUM) is a Strong Momentum Stock
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Humana (HUM) is a Strong Value Stock
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Humana (HUM) is a Top Momentum Stock for the Long-Term
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.
Read More
Humana Inc. (HUM) Q2 2025 Earnings Call Transcript
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Humana Inc. (NYSE:HUM ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Celeste Marie Mellet - Chief Financial Officer George Renaudin - President of Insurance James A. Rechtin - President, CEO & Director Lisa M.
Read More
Top Stock Movers Now: Humana, Hershey, VF Corp., and More
Published: July 30, 2025 by: Investopedia
Sentiment: Positive
U.S. equities were mixed at midday as the market responded to the U.S. economy growing more than expected in the second quarter while waiting for today's decision by the Federal Reserve on interest rates. The S&P 500 and Nasdaq gained, but the Dow Jones Industrial Average fell.
Read More
Humana Boosts Outlook on Lower-Than-Expected Medicare Advantage Membership Drop
Published: July 30, 2025 by: Investopedia
Sentiment: Positive
Humana (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought.
Read More
Here's What Key Metrics Tell Us About Humana (HUM) Q2 Earnings
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Humana (HUM) Q2 Earnings Lag Estimates
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Humana (HUM) came out with quarterly earnings of $6.27 per share, missing the Zacks Consensus Estimate of $6.32 per share. This compares to earnings of $6.96 per share a year ago.
Read More
Has Humana turned the corner? Stock jumps as outlook raised, Medicare business improves
Published: July 30, 2025 by: Market Watch
Sentiment: Positive
Humana's stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.
Read More
Insurer Humana raises annual profit forecast, shares climb
Published: July 30, 2025 by: Reuters
Sentiment: Positive
Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher medical costs that have plagued the sector, sending its shares up nearly 6% in premarket trading.
Read More
Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance
Published: July 30, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2025 (2Q25) versus the quarter ended June 30, 2024 (2Q24) and for the six months ended June 30, 2025 (YTD 2025) versus the six months ended June 30, 2024 (YTD 2024) as noted in the tables below. Consolidated income before income taxes and equity in net losses 2Q25 (a) 2Q24 (a) YTD 2025 (a) YTD 2024 (a) Generally Accepted Accou.
Read More
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
HUM's second-quarter earnings are likely to have witnessed strength in insurance premiums and Medicare, partly offset by rising costs and membership declines.
Read More
Humana (HUM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Stock Of The Day: Is It Time To Buy Humana?
Published: July 16, 2025 by: Benzinga
Sentiment: Positive
Humana Inc. HUM is consolidating on Wednesday. But it may be about to reverse and rally.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Humana Simplifies Access to Coverage and Care Information
Published: July 15, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana simplifies access to coverage and care information with first-of-its-kind MyChart integration.
Read More
Humana Foundation Responds to Central Texas Flood Tragedy with $500,000 in Recovery Support
Published: July 08, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today a $500,000 donation to aid recovery efforts in Central Texas following the tragic flooding that struck over the July 4 holiday weekend. The Humana Foundation is coordinating efforts with its partner in the region, Reach Resilience, and is matching their donation of $500,000. The catastrophic flooding has claimed the lives of at least 109 individuals, including 28 children. Amon.
Read More
Humana Launches Medicaid Plan in Virginia
Published: July 02, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana launches Medicaid plan in Virginia.
Read More
Is Humana (HUM) a Great Value Stock Right Now?
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
4 HMO Stocks Set to Thrive From Steady Premium Flows, M&A Strategy
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks Medical-HMO industry players. CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Read More
National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location
Published: June 25, 2025 by: Business Wire
Sentiment: Neutral
WASHINGTON--(BUSINESS WIRE)--National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location.
Read More
Humana: Margin Over Volume Signals A Buy
Published: June 24, 2025 by: Seeking Alpha
Sentiment: Positive
I maintain a Buy rating on Humana due to robust revenue growth and expanding margins, driven by strong demand in core markets. Management's guidance for the next quarter remains optimistic, supported by new product launches and recent customer wins. Valuation remains attractive relative to peers, with the stock trading at a discount despite superior earnings momentum and free cash flow generation.
Read More
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Published: June 12, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana recognizes 10 inspiring National Senior Games athletes who are redefining what it means to age.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
Humana to back curbs to Medicare Advantage billing practices, WSJ reports
Published: June 05, 2025 by: Reuters
Sentiment: Neutral
Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.
Read More
Humana, the second-biggest Medicare insurer, has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry
Published: June 05, 2025 by: WSJ
Sentiment: Neutral
The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
Published: June 04, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
About Humana Inc. (HUM)
- IPO Date 1981-12-31
- Website https://www.humana.com
- Industry Medical - Healthcare Plans
- CEO James A. Rechtin
- Employees 65680